References
- Wagner LI, Cella D. Fatigue and cancer: causes, prevalence and treatment approaches. Br. J. Cancer91, 822–828 (2004).
- Henry DH, Viswanathan HN, Elkin EP et al. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional survey in the US. Support Care Cancer16, 791–801 (2008).
- Cella D, Davis K, Breitbart W, Curt G. Cancer related fatigue: prevalence of porposed diagnostic criteria in a United States sample of cancer survivors. J. Clin. Oncol.19, 3385–3391 (2001).
- Servaes P, van-der-Werf S, Prins J, Verhagen S, Bleijenberg G. Fatigue in disease-free cancer patients compared with fatigue in patients with chronic fatigue syndrome. Support Care Cancer9, 11–17 (2001).
- Irvine D, Vincent L, Graydon J. Bubela N, Thompson L. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. Cancer Nurs.17(5), 367–378 (1994).
- Morrow GR, Andrews PL, Hickok JT et al. Fatigue associated with cancer and its treatment. Support Care Cancer10, 389–398 (2002).
- Stone P, Richardson A, Ream E, Smith A, Kerr D, Kearney N. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-center patient survey. Cancer Fatigue Forum. Ann. Oncol.11(8), 971–975 (2000).
- Ruffer JU, Flechtner H, Tralls P et al. Fatigue in long-term survivors of Hodgkin’s lymphoma: a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur. J. Cancer39, 2179–2186 (2003).
- Berglund G, Boland C, Fornandes T et al. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur. J. Cancer27, 1075–1081 (1991).
- Bower J, Ganz P, Demsond K, Rowland J, Meyerowitz B, Belin R. Fatigue in breast cancer survivors: occurrence, correlates, an impact of quality of life. J. Clin. Oncol.18, 743–753 (2000).
- Olson K, Krawchuk A, Quddusi T. Fatigue in individuals with advanced cancer in active treatment and palliative settings. Cancer Nurs.30, E1–10 (2007).
- Curt G, Breitbart W, Cella D et al. Impact of cancer related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist5, 353–360 (2000).
- Passik SD, Kirsh KL, Donaghy K et al. Patient related barriers to fatigue communication: initial validation of the fatigue management barriers questionnaires. J. Pain Symptom Manage.24, 481–449 (2002).
- Stone P, Richardson A, Ream E et al. Cancer-related fatigue: inevitable, unimportant, and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann. Oncol.11, 971–975 (2000).
- Servaes P, Verhagen S, Schreuder HW et al. Fatigue after treatment for malignant and benign bone and soft tissue tumors. J. Pain Symptom Manage.26, 1113–1122 (2003).
- Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur. J. Cancer38, 27–43 (2002).
- Neitzert C, Ritvo P, Dancey J, Weiser K, Murray C, Avery J. The psychosocial impact of bone marrow transplantation: a review of the literature. Bone Marrow Transplant.22, 409–422 (1998).
- Bower JE. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav. Immun.21, 863–871 (2007).
- Schubert C, Hong S, Natarajan L et al. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav. Immun.21, 413–427 (2007).
- Strasser F, Palmer JL, Schover LR et al. The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study. Cancer107, 2949–2957 (2006).
- Berger AM, Wielgus K, Hertzog M et al. Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy. Support Care Cancer18, 105–114 (2010).
- Rich TA. Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis. J. Support Oncol.5, 167–174 (2007).
- Morrow GR, Hickok JT, Andrews PL et al. Reduction in serum cortisol after platinum based chemotherapy for cancer: a role for the HPA axis in treatment-related nausea? Psychophysiology39, 491–495 (2002).
- Miller AH, Ancoli-Israel S, Bower JE et al. Neuroendocrine immune mechanisms of behavioral comorbidities in patients with cancer. J. Clin. Oncol.26, 971–982 (2008).
- Ancoli-Israel S, Moore PJ, Jones V. The relationship between fatigue and sleep in cancer patients: a review. Eur. J. Cancer Care10, 245–255 (2001).
- Hinds PD, Hockenberry M, Rai SN et al. Nocturnal awakenings, sleep environment interruptions, and fatigue in hospitalized children with cancer. Oncol. Nurs. Forum34, 393–402 (2007).
- Loge J, Abrahamsen A, Ekeberg O, Kaasa S. Fatigue and psychiatric morbidity among Hodgkin’s disease survivor. J. Pain Symptom Manage.19(2), 91–99 (2000).
- Patrick DL, Ferketich SL, Frame PS et al. National Institutes of Health state-of-the-science conference statement: symptom management in cancer: pain, depression, and fatigue, July 15–17, 2002. J. Natl Cancer Inst.95, 1110–1117 (2003).
- Valentine A, Meyers C. Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer96(Suppl. 6), 1694–1698 (2001).
- Visser M, Smets E. Fatigue, depression and quality of life in cancer patients: how are they related? Support Care Cancer,6, 101–108 (1998).
- Hayes J. Depression and chronic fatigue in cancer patients. Prim. Care18(2), 327–339 (1991).
- Gaston-Johansson F, Fall-Dickson J, Bakos A, Kennedy M. Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Practice7(5), 240–247 (1999).
- Glaus A. Fatigue in Patients with Cancer: Analysis and Assessment. Heidelberg: Springer, Berlin, Germany (1998).
- Wettergren L, Langius A, Björkholm M, Björvell H. Physical and psychosocial functioning in patients undergoing autologous bone marrow transplantation – a prospective study. Bone Marrow Transplant.20, 497–502 (1997).
- Ashbury F, Findlay H, Reynolds B, McKerracher K. A canadian survey of cancer patients’ experiences: are their needs being met? J. Pain Symptom Manage.16(5), 298–306 (1998).
- Spelten ER, Verbeek JAHM, Uitterhoeve ALJ et al. Cancer, fatigue and the return of patients to work – a prospective cohort study. Eur. J. Cancer39, 1562–1567 (2003).
- Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet362, 640–650 (2003).
- Butt Z, Wagner LI, Beaumont JL. Use of a single item screening instrument to detect clinically relevant fatigue, distress, pain and anorexia in ambulatory cancer practice. J. Pain Symptom Manage.35, 20–30 (2008).
- Cella D. The functional assessment of Cancer Therapy Anemia and Fatigue Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Seminar Hematolog.34(3), 13–19 (1997).
- Mendoza TR, Wang XS, Kugaya A et al. The rapid assessment of fatigue severity in cancer patients; use of the brief Fatigue Inventory. Cancer85(5), 1186–1196 (1999).
- Smets EMA, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychometric Res.39(5), 315–325 (1995).
- Perneger T, Leplege A, Etter J. Cross-cultural adaptation of a psychometric instrument: two methods compared. J. Clin. Epidemiol.52, 1037–1046 (1999).
- Morrow GR, Shelke AR, Roscoe JA et al. Management of cancer-related fatigue. Cancer Invest.23, 229–239 (2005).
- Hinds PS, Quargneti A, Bush AJ et al. An evaluation of the impact of a self-care coping intervention on psychological and clinical outcomes in adolescents with newly diagnosed cancer. Eur. J. Oncol. Nurs.4, 6–19 (2000).
- Mitchell SA, Beck SL, Hood LE et al. Putting evidence into practise: evidence-based interventions for fatigue during and following cancer and its treatment. Clin. J. Oncol. Nurs.11, 99–113 (2007).
- Barsevick AM, Dudley W, Beck S et al. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer100, 1302–1310 (2004).
- Mock V, Frangakis C, Davidson NE et al. Exercise manages fatigue during breast cancer treatment: a randomized controlled trial. Psychooncology14, 464–477 (2005).
- Schwartz AL. Daily fatigue patterns and effect of exercise in women with breast cancer. Cancer Pract.8, 16–24 (2000).
- Schwartz AL, Mori M, Gao R et al. Exercise reduces daily fatigue in women with breast cancer receiving chemotherapy. Med. Sci. Sports Exerc.33, 718–723 (2001).
- Cramp F, Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst. Rev.16(2), CD006145 (2008).
- Schmitz KH, Courneya KS, Matthews C et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med. Sci. Sports Exerc.42, 1409–1426 (2010).
- Zick SM, Alrawi S, Merel G et al. Relaxation acupressure reduces persistent cancer-related fatigue. Evid. Based Complement. Alternat. Med.2011, pii: 142913 (2011).
- Sood A, Barton DL, Bauer BA, Loprinzi CL. A critical review of complementary therapies for cancer-related fatigue. Integr. Cancer Ther.6, 8–13 (2007).
- Kim SD, Kim HS. Effects of a relaxation breathing exercise on fatigue in haemopoietic stem cell transplantation patients. J. Clin. Nurs.14, 51–55 (2005).
- Carlson LE, Garland SN. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int. J. Behav. Med.12, 278–285 (2005).
- Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G. Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst. Rev.CD006953 (2009).
- Jacobsen PB, Donovan KA, Vadaparamil ST, Small BJ. Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol.26, 660–667 (2007).
- Mar Fan HG, Clemons M, Xu W et al. A randomised, placebo-controlled, double-blind trial of the effects of D-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Center16, 577–583 (2008).
- Moraska AR, Sood A, Dakhil SR et al. Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Treatment Group NCCTG-N05C7 trial. J. Clin. Oncol.28, 3673–3367 (2010).
- Lasheen W, Walsh, D, Mahmoud F et al. Methylphenidate side effects in advanced cancer: a retrospective analysis. Am. J. Hosp. Palliat. Care27(1), 16–23 (2010).
- Lower EE, Fleishman S, Cooper A et al. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. J. Pain Symptom Manage.38(5), 650–662 (2009).
- Cooper MR, Bird HM, Steinberg M, Efficacy and safety of modafinil in the treatment of cancer-related fatigue. Ann. Pharmacother.43, 721–725 (2009).
- Jean-Pierre P, Morrow GR, Roscoe JA et al. A Phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer116, 3513–3520 (2010).
- Cruciani RA, Dvorkin E, Homel P et al.L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysis. Ann. NY Acad. Sci.1033, 168–176 (2004).
- Barton DL, Soori GS, Bauer BA et al. Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Cancer Care,18, 179–187 (2010).
- Minton O, Richardson A, Sharpe M et al. Drug therapy for the management of cancer-related fatigue. Cochrane Database Syst. Rev.7, CD006704 (2010).
- Peuckmann-Post V, Elsner F, Krumm N, Trottenberg R, Radbruch L, Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst. Rev.10(11), CD006788 (2010).
Website
- National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Cancer Related Fatigue. Version 1.2011 (2011) www.nccn.org/professionals/physician_gls/f_guidelines.asp